Neuromod Devices has secured €10m ($10.8m) in equity financing to broaden the reach of Lenire, its treatment device.

Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a €10 ...

Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...

Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...

The start-up intends to use the latest infusion to further fuel the European commercialisation of its tinnitus device Lenire, as well as to scale up its manufacturing and progress its US Food and ...

Irish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...

Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a ?10 million equity financing to expand the availability of its tinnitus treatment ...

In June 2024, Neuromod was awarded a Federal Supply Schedule 65 II Medical Equipment and Supply Contract from the US Government, making Lenire a treatment option for the 2.9 million US Veterans ...

Irish medical device company Neuromod Devices has received €10m ($10.8m) in equity financing to broaden the reach of Lenire, its tinnitus treatment device. Current investors Panakès Partners ...

Neuromod has been making Lenire available through audiology and ENT practices throughout the USA and Europe. Proceeds from the financing will be used to meet demand for Lenire through sustainable ...